Manta™ Versus Suture-based Closure After Transcatheter Aortic Valve Implantation Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 151 participants.

Also called NCT03811119

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 151 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03811119
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03811119. Randomized; no masking; primary purpose treatment. Start 2018-10-30 (actual); primary completion 2020-02-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Manta™ Versus Suture-based Closure After Transcatheter Aortic Valve Implantation Trial
Acronym
MASH-TAVI
Condition
Aortic Valve Stenosis
Intervention (Device)
MANTA vascular closure device
Intervention (Device)
Suture based vascular closure device
Lead sponsor
Erasmus Medical Center (class: other)

Record details

Record id
cardio:ct-nct03811119
Content hash
1202d29617cd4df9bed58d60d5545247e955ec69c616b5a4a9d3da9885840905